A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of " optimal" therapy

Breast

Volumn 21, Issue 4, 2012, Pages 562-569

  Fong, Andrew ^a,b   Shafiq, Jesmin ^a,b   Saunders, Christobel ^e   Thompson, Alastair ^d   Tyldesley, Scott ^c   Olivotto, Ivo A ^c   Barton, Michael B ^a,b   Dewar, John A ^d   Jacob, Susannah ^a,b   Ng, Weng ^a,b   Speers, Caroline ^c   Delaney, Geoff P ^a,b,f  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Breast cancer; Cancer; Chemotherapy; Endocrine therapy; Evidence based medicine; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANADA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER STAGING; COMPARATIVE STUDY; DEMOGRAPHY; EVIDENCE BASED MEDICINE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 84863882613     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.01.006     Document Type: Article

References (22)

1. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106. [Epub 2005/12/20].
2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365(9472):1687-1717. [Epub 2005/05/17].
3. Delaney G., Shafiq J., Chappell G., Barton M. Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines. Cancer 2008, 112(9):1912-1922. [Epub 2008/03/06].
4. Delaney G., Barton M., Jacob S. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer 2003, 98(9):1977-1986. [Epub 2003/10/30].
5. Tyldesley S., McGahan C. Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer. Clin Oncol (R Coll Radiol) 2010, 22(7):526-532.
6. Ng W., Delaney G.P., Jacob S., Barton M.B. Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care. Eur J Cancer 2010, 46(4):703-712. [Epub 2009/12/26].
7. Fong A., Ng W., Barton M.B., Delaney G.P. Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer. Breast 2010, [Epub 2010/03/13].
8. Clinical practice guidelines for the management of early breast cancer 2001, National Breast Cancer Centre, Canberra.
9. Clinical practice guidelines for the management of advanced breast cancer 2001, National Breast Cancer Centre, Canberra.
10. National practice guidelines in oncology - breast cancer 2008, National Comprehensive Cancer Network.
11. British Columbia Cancer Agency cancer management guidelines: breast cancer 2009, Available from:, [cited 2009 22 June]. http://www.bccancer.bc.ca.
12. Early and locally advanced breast cancer: diagnosis and treatment 2009, National Collaborating Centre for Cancer, Cardiff.
13. Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thurlimann B., Senn H.J. Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009, 20(8):1319-1329. [Epub 2009/06/19].
14. Centre for Epidemiology and Research 2005 report on adult health from the New South Wales population health Survey 2006, NSW Department of Health, Sydney.
15. Australian Association of Cancer Registries Cancer in Australia 2003 2007, Australian Institute of Health and Welfare, Canberra.
16. Breast cancer treatment (PDQ) 2009, National Cancer Institute, Available from:, [cited 2009 1 November]. http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional.
17. Munro B. Statistical methods for health care research 2001, Lippincott William and Wilkins, Philadelphia. 4th ed.
18. Goldhirsch A., Glick J.H., Gelber R.D., Coates A.S., Senn H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 2001, 19(18):3817-3827. [Epub 2001/09/18].
19. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., Senn H.J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003, 21(17):3357-3365. [Epub 2003/07/09].
20. Management of breast cancer in women: a national clinical guideline 2005, Edinburgh. Network SIG (Ed.).
21. Duric V., Stockler M., Heritier S., Boyle F., Beith J., Sullivan A., et al. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?. Ann Oncol 2005, 16(11):1786-1794.
22. Simes R., Coates A. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?. J Natl Cancer Inst Monogr 2001, 30:146-152.